Corporate
Compass Pathways Stock Surges 36% as Psilocybin Therapy COMP360 Hits 3-for-3 in Phase 3 Trials
Feb 17
You're signed outSign in or to get full access.
COMPASS Pathways (CMPS) Earnings Call Transcripts
Browse quarterly earnings call transcripts for COMPASS Pathways.
Q3 2025
Nov 4, 2025
Q2 2025
Jul 31, 2025
Q1 2025
May 8, 2025
Q4 2024
Feb 27, 2025
Q3 2024
Oct 31, 2024
Q2 2024
Aug 1, 2024
Q1 2024
May 8, 2024
Q4 2023
Feb 29, 2024
Q3 2023
Nov 2, 2023
Q2 2023
Aug 3, 2023
Q2 2021
Aug 11, 2021
